Newly developed cell transplantation delivery method could treat traumatic brain injury

Treating traumatic brain injury (TBI) using stem cell therapy is an important area of current research. However, injecting stem cells into the central nervous system has serious drawbacks, including intracranial hemorrhage and cells failing to reach TBI-affected areas of the brain.

Now, a research team from the University of Maryland, Baltimore and the Veterans Administration Maryland Healthcare System has successfully directed human (hNPCs) to injured brain areas by labeling them with iron-oxide "superparamagnetic nanoparticles" and guiding them to the site of injury using a magnetic field. Tested on rats modeled with TBI, they found that the magnetic field delivery method does not affect the viability of hNPCs and that the method provides both increased homing to the injury site as well as retention of the transplanted cells.

Their study will be published in a future issue of Cell Transplantation and is currently freely available on-line.

"Magnetic cell targeting is ideally suited to augmenting cell therapies," said study lead author Dr. Paul Yarowsky, of the University of Maryland School of Medicine and the VA Maryland Healthcare System. "The and field gradient can guide cells to sites of injury and, using MRI, the iron-oxide superparamagnetic nanoparticles can be visualized as they travel to the site of injury. The goal when employing this method is not only guiding the particles to the site of injury, but also enhancing entry into the brain and the subsequent retention of ."

The researchers reported that the intensity of the magnetic field does not affect the in vitro viability, proliferation or differentiation of cells loaded with iron oxide nanoparticles. These results, said the researchers, suggest that the method is a "promising technique" for cell delivery in TBI and other neurological injuries and neurodegenerative diseases.

Questions remain, however. For example, what happens to the when the magnetic field is no longer present? Also, what are the limits to magnetic intensity - could the cells "clump" together in a more ? Additionally, what is the minimum length of time the "magnetic hat" must be in place for successful ?

Although the optimized magnetic intensity obtained for small animal studies must be extrapolated to larger animals, the researchers concluded that "taken together, our results show that magnetic retention of labeled particles is a promising cell therapy for delivery in TBI with potential for clinical translation."

The researchers are currently assessing long-term changes in hNPC viability and differentiation following magnetic retention, and also investigating the transplant method's enhancement of functional recovery following TBI.

"The significance of this study lies in the fact the method used circumvented the need for invasive transplantation procedures, such as intracerebroventricular injection," said Dr. John R. Sladek, Jr., professor of Neurology, Pediatrics, and Neuroscience, Department of Neurology at the University of Colorado School of Medicine and section editor for Cell Transplantation. "Furthermore, use of a magnetic field to increase homing of cells, which can be problematic, to the target tissue proved efficacious. Future studies should explore whether this method would be safe and effective for humans, as it would necessitate a more intense in order to increase migration of to deeper regions of the brain parenchyma."

More information: Shen, W.-B.; Plachez, C.; Tsymbalyuk, O.; Tsymbalyuk, N.; Xu, S.; Yarnell, D.; Mullins, R.; Gulapalli, R.; Puche, A.; Simard, J. M.; Fishman, P. S.; Yarowsky, P. Cell-based therapy in TBI: Magnetic retention of neural stem cells in vivo.. Cell Transplant. Appeared or available on-line: September 21, 2015. … t-CT-1424_Shen_et_al
Journal information: Cell Transplantation

Citation: Newly developed cell transplantation delivery method could treat traumatic brain injury (2015, October 29) retrieved 29 November 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Regenerative Medicine gives a much needed update on magnetic tracking in cell therapy


Feedback to editors